Differential striatal spine pathology in Parkinson's disease and cocaine addiction: A key role of dopamine?

Neuroscience

Volumn 251, Issue , 2013, Pages 2-20

  Villalba, R M ^a   Smith, Y ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 OHDA; Accumbens; CaM; CAMP; CaN; Cdk5; Cocaine; Corticostriatal; DA; Glutamate; GP; MEF2; MSNs; NAc; PD; PKA; PSD; RCS; RRA; SN; SNc; SNr; STN; Striatum; SynCAM1; Thalamostriatal; VGluT1; VGluT2; VTA

Indexed keywords

CYCLIN DEPENDENT KINASE 5; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DYNORPHIN; ENKEPHALIN; MYOCYTE ENHANCER FACTOR 2; PSYCHOSTIMULANT AGENT; SUBSTANCE P; TRANSCRIPTION FACTOR FOSB;

BASAL GANGLION; CELL LOSS; COCAINE DEPENDENCE; DENDRITIC SPINE; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG EXPOSURE; GABAERGIC SYSTEM; GENETIC ASSOCIATION; HUMAN; INTRACELLULAR SIGNALING; LONG TERM EXPOSURE; MEDIUM SPINY NEURON; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEX DIFFERENCE; STRIATONIGRAL DEGENERATION; SYNAPTIC TRANSMISSION;

6-HYDROXYDOPAMINE; 6-OHDA; ACCUMBENS; CALCINEURIN; CALMODULIN; CAM; CAMP; CAN; CDK5; COCAINE; CORTICOSTRIATAL; CYCLIC AMP; CYCLIN-DEPENDENT KINASE 5; DA; DOPAMINE; GLOBUS PALLIDUS; GLUTAMATE; GP; MEDIUM SPINY NEURONS; MEF2; MSNS; MYOCYTE ENHANCER FACTOR 2; NAC; NUCLEUS ACCUMBENS; PARKINSON'S DISEASE; PD; PKA; POSTSYNAPTIC DENSITIES; PROTEIN KINASE A; PSD; RCS; REGULATOR OF CALMODULIN SIGNALING; RETRORUBRAL AREA; RRA; SN; SNC; SNR; STN; STRIATUM; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; SYNAPTIC CELL ADHESION MOLECULE 1; SYNCAM1; THALAMOSTRIATAL; VENTRAL TEGMENTAL AREA; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; VGLUT1; VGLUT2; VTA;

ANIMALS; BASAL GANGLIA; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; DENDRITIC SPINES; DOPAMINE; DOPAMINERGIC NEURONS; GABAERGIC NEURONS; HUMANS; MEF2 TRANSCRIPTION FACTORS; NUCLEUS ACCUMBENS; PARKINSON DISEASE;

EID: 84884417232     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.07.011     Document Type: Review

References (269)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989, 12:366-375.
2. Alcantara-Gonzalez F., Juarez I., Solis O., Martinez-Tellez I., Camacho-Abrego I., Masliah E., Mena R., Flores G. Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration. Synapse 2010, 64:786-793.
3. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986, 9:357-381.
4. Alexander G.E., Crutcher M.D., DeLong M.R. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990, 85:119-146.
5. Anglade P., Mouatt-Prigent A., Agid Y., Hirsch E. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration 1996, 5:121-128.
6. Antzoulatos E., Jakowec M.W., Petzinger G.M., Wood R.I. MPTP neurotoxicity and testosterone induce dendritic remodeling of striatal medium spiny neurons in the C57Bl/6 mouse. Parkinsons Dis 2011, 2011:138471.
7. Arbuthnott G.W., Wickens J. Space, time and dopamine. Trends Neurosci 2007, 30:62-69.
8. Arbuthnott G.W., Ingham C.A., Wickens J.R. Modulation by dopamine of rat corticostriatal input. Adv Pharmacol 1998, 42:733-736.
9. Arbuthnott G.W., Ingham C.A., Wickens J.R. Dopamine and synaptic plasticity in the neostriatum. J Anat 2000, 196(Pt 4):587-596.
10. Azdad K., Chavez M., Don Bischop P., Wetzelaer P., Marescau B., De Deyn P.P., Gall D., Schiffmann S.N. Homeostatic plasticity of striatal neurons intrinsic excitability following dopamine depletion. PLoS One 2009, 4:e6908.
11. Ball K.T., Wellman C.L., Fortenberry E., Rebec G.V. Sensitizing regimens of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat. Neuroscience 2009, 160:264-274.
12. Berendse H.W., Galis-de Graaf Y., Groenewegen H.J. Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 1992, 316:314-347.
13. Bernacer J., Prensa L., Gimenez-Amaya J.M. Morphological features, distribution and compartmental organization of the nicotinamide adenine dinucleotide phosphate reduced-diaphorase interneurons in the human striatum. J Comp Neurol 2005, 489:311-327.
14. Bernacer J., Prensa L., Gimenez-Amaya J.M. Cholinergic interneurons are differentially distributed in the human striatum. PLoS One 2007, 2:e1174.
15. Bernacer J., Prensa L., Gimenez-Amaya J.M. Distribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum. PLoS One 2012, 7:e30504.
16. Berridge C.W., Stratford T.L., Foote S.L., Kelley A.E. Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 1997, 27:230-241.
17. Bezard E. Treating Parkinson's disease: preserve the spines! (Commentary on Soderstrom et al.). Eur J Neurosci 2010, 31:477.
18. Bolam J.P., Pissadaki E.K. Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord 2012, 27:1478-1483.
19. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organisation of the basal ganglia. J Anat 2000, 196(Pt 4):527-542.
20. Bonhoeffer T., Yuste R. Spine motility. Phenomenology, mechanisms, and function. Neuron 2002, 35:1019-1027.
21. Boudreau A.C., Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci 2005, 25:9144-9151.
22. Bourne J.N., Harris K.M. Balancing structure and function at hippocampal dendritic spines. Annu Rev Neurosci 2008, 31:47-67.
23. Breakefield X.O., Blood A.J., Li Y., Hallett M., Hanson P.I., Standaert D.G. The pathophysiological basis of dystonias. Nat Rev Neurosci 2008, 9:222-234.
24. Brown R.W., Kolb B. Nicotine sensitization increases dendritic length and spine density in the nucleus accumbens and cingulate cortex. Brain Res 2001, 899:94-100.
25. Calabresi P., Picconi B., Tozzi A., Di Filippo M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 2007, 30:211-219.
26. Campana A.D., Sanchez F., Gamboa C., Gomez-Villalobos Mde J., De La Cruz F., Zamudio S., Flores G. Dendritic morphology on neurons from prefrontal cortex, hippocampus, and nucleus accumbens is altered in adult male mice exposed to repeated low dose of malathion. Synapse 2008, 62:283-290.
27. Cardinal R.N., Everitt B.J. Neural and psychological mechanisms underlying appetitive learning: links to drug addiction. Curr Opin Neurobiol 2004, 14:156-162.
28. Centonze D., Grande C., Usiello A., Gubellini P., Erbs E., Martin A.B., Pisani A., Tognazzi N., Bernardi G., Moratalla R., Borrelli E., Calabresi P. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci 2003, 23:6245-6254.
29. Chen Y., Dube C.M., Rice C.J., Baram T.Z. Rapid loss of dendritic spines after stress involves derangement of spine dynamics by corticotropin-releasing hormone. J Neurosci 2008, 28:2903-2911.
30. Cheng H.W., Rafols J.A., Goshgarian H.G., Anavi Y., Tong J., McNeill T.H. Differential spine loss and regrowth of striatal neurons following multiple forms of deafferentation: a Golgi study. Exp Neurol 1997, 147:287-298.
31. Colby C.R., Whisler K., Steffen C., Nestler E.J., Self D.W. Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J Neurosci 2003, 23:2488-2493.
32. Costa R.M. Plastic corticostriatal circuits for action learning: what's dopamine got to do with it?. Ann N Y Acad Sci 2007, 1104:172-191.
33. Cotman C., Nieto-Sampedro M. Brain function, synapse renewal, and plasticity. Annu Rev Psychol 1982, 33:371-401.
34. Cragg S.J., Rice M.E. DAncing past the DAT at a DA synapse. Trends Neurosci 2004, 27:270-277.
35. Crombag H.S., Gorny G., Li Y., Kolb B., Robinson T.E. Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb Cortex 2005, 15:341-348.
36. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 1999, 122(Pt 8):1421-1436.
37. Damier P., Hirsch E.C., Agid Y., Graybiel A.M. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999, 122(Pt 8):1437-1448.
38. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
39. Day M., Wang Z., Ding J., An X., Ingham C.A., Shering A.F., Wokosin D., Llijic E., Sun Z., Sampson A.R., Mugnaini E., Deutch A.Y., Sesack S.R., Arbuthnott G.W., Surmeier D.J. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006, 9:251-259.
40. Day M., Wokosin D., Plotkin J.L., Tian X., Surmeier D.J. Differential excitability and modulation of striatal medium spiny neuron dendrites. J Neurosci 2008, 28:11603-11614.
41. Delle Donne K.T., Sesack S.R., Pickel V.M. Ultrastructural immunocytochemical localization of neurotensin and the dopamine D2 receptor in the rat nucleus accumbens. J Comp Neurol 1996, 371:552-566.
42. Delle Donne K.T., Sesack S.R., Pickel V.M. Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res 1997, 746:239-255.
43. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990, 13:281-285.
44. DeLong M.R., Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007, 64:20-24.
45. Deutch A.Y. Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. J Neural Transm Suppl 2006, 67-70.
46. Deutch A.Y., Colbran R.J., Winder D.J. Striatal plasticity and medium spiny neuron dendritic remodeling in parkinsonism. Parkinsonism Relat Disord 2007, 13(Suppl. 3):S251-S258.
47. Diana M., Spiga S., Acquas E. Persistent and reversible morphine withdrawal-induced morphological changes in the nucleus accumbens. Ann N Y Acad Sci 2006, 1074:446-457.
48. Dietz D.M., Dietz K.C., Moore S., Ouimet C.C., Kabbaj M. Repeated social defeat stress-induced sensitization to the locomotor activating effects of d-amphetamine: role of individual differences. Psychopharmacology (Berl) 2008, 198:51-62.
49. Dobi A., Seabold G.K., Christensen C.H., Bock R., Alvarez V.A. Cocaine-induced plasticity in the nucleus accumbens is cell specific and develops without prolonged withdrawal. J Neurosci 2011, 31:1895-1904.
50. Dumitriu D., Laplant Q., Grossman Y.S., Dias C., Janssen W.G., Russo S.J., Morrison J.H., Nestler E.J. Subregional, dendritic compartment, and spine subtype specificity in cocaine regulation of dendritic spines in the nucleus accumbens. J Neurosci 2012, 32:6957-6966.
51. Ellender T.J., Huerta-Ocampo I., Deisseroth K., Capogna M., Bolam J.P. Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. J Neurosci 2011, 31:15340-15351.
52. Esparza M.A., Bollati F., Garcia-Keller C., Virgolini M.B., Lopez L.M., Brisco A., Shen H.W., Kalivas P.W., Cancela L.M. Stress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nuclei. Eur J Neurosci 2012, 36:3103-3117.
53. Fasano C., Bourque M.J., Lapointe G., Leo D., Thibault D., Haber M., Kortleven C., Desgroseillers L., Murai K.K., Trudeau L.E. Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors. Neuropharmacology 2013, 67:432-443.
54. Ferrario C.R., Gorny G., Crombag H.S., Li Y., Kolb B., Robinson T.E. Neural and behavioral plasticity associated with the transition from controlled to escalated cocaine use. Biol Psychiatry 2005, 58:751-759.
55. 2+ entry in nucleus accumbens dendritic spines. PLoS One 2012, 7:e40898.
56. Fiala J.C., Spacek J., Harris K.M. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain Res Brain Res Rev 2002, 39:29-54.
57. Fifkova E., Markham J.A., Delay R.J. Calcium in the spine apparatus of dendritic spines in the dentate molecular layer. Brain Res 1983, 266:163-168.
58. Flavell S.W., Cowan C.W., Kim T.K., Greer P.L., Lin Y., Paradis S., Griffith E.C., Hu L.S., Chen C., Greenberg M.E. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 2006, 311:1008-1012.
59. Flores C., Wen X., Labelle-Dumais C., Kolb B. Chronic phencyclidine treatment increases dendritic spine density in prefrontal cortex and nucleus accumbens neurons. Synapse 2007, 61:978-984.
60. Forlano P.M., Woolley C.S. Quantitative analysis of pre- and postsynaptic sex differences in the nucleus accumbens. J Comp Neurol 2010, 518:1330-1348.
61. Frankfurt M., Wang H.Y., Marmolejo N., Bakshi K., Friedman E. Prenatal cocaine increases dendritic spine density in cortical and subcortical brain regions of the rat. Dev Neurosci 2009, 31:71-75.
62. Frankfurt M., Salas-Ramirez K., Friedman E., Luine V. Cocaine alters dendritic spine density in cortical and subcortical brain regions of the postpartum and virgin female rat. Synapse 2011, 65:955-961.
63. Fremeau R.T., Kam K., Qureshi T., Johnson J., Copenhagen D.R., Storm-Mathisen J., Chaudhry F.A., Nicoll R.A., Edwards R.H. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 2004, 304:1815-1819.
64. Fremeau R.T., Voglmaier S., Seal R.P., Edwards R.H. VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 2004, 27:98-103.
65. Freund T.F., Powell J.F., Smith A.D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience 1984, 13:1189-1215.
66. Fudge J.L., Kunishio K., Walsh P., Richard C., Haber S.N. Amygdaloid projections to ventromedial striatal subterritories in the primate. Neuroscience 2002, 110:257-275.
67. Fujiyama F., Furuta T., Kaneko T. Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J Comp Neurol 2001, 435:379-387.
68. Galvan A., Smith Y. The primate thalamostriatal systems: anatomical organization, functional roles and possible involvement in Parkinson's disease. Basal Ganglia 2011, 1:179-189.
69. Garcia B.G., Neely M.D., Deutch A.Y. Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss. Cereb Cortex 2010, 20:2423-2432.
70. Gerfen C.R. Indirect-pathway neurons lose their spines in Parkinson disease. Nat Neurosci 2006, 9:157-158.
71. Gerfen C.R., Surmeier D.J. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 2011, 34:441-466.
72. Gerfen C.R., Herkenham M., Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 1987, 7:3915-3934.
73. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990, 250:1429-1432.
74. Gertler T.S., Chan C.S., Surmeier D.J. Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci 2008, 28:10814-10824.
75. Gipson C.D., Kupchik Y.M., Shen H., Reissner K.J., Thomas C.A., Kalivas P.W. Relapse induced by cues predicting cocaine depends on rapid, transient synaptic potentiation. Neuron 2013, 77:867-872.
76. Giza J.I., Jung Y., Jeffrey R.A., Neugebauer N.M., Picciotto M.R., Biederer T. The synaptic adhesion molecule SynCAM 1 contributes to cocaine effects on synapse structure and psychostimulant behavior. Neuropsychopharmacology 2013, 38:628-638.
77. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L.A., Marshall J., Mao Z. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003, 38:33-46.
78. Graybiel A.M. Network-level neuroplasticity in cortico-basal ganglia pathways. Parkinsonism Relat Disord 2004, 10:293-296.
79. Graybiel A.M. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008, 31:359-387.
80. Groenewegen H.J., Wright C.I., Beijer A.V. The nucleus accumbens: gateway for limbic structures to reach the motor system?. Prog Brain Res 1996, 107:485-511.
81. Groves P.M., Linder J.C., Young S.J. 5-hydroxydopamine-labeled dopaminergic axons: three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum. Neuroscience 1994, 58:593-604.
82. Grueter B.A., Rothwell P.E., Malenka R.C. Integrating synaptic plasticity and striatal circuit function in addiction. Curr Opin Neurobiol 2012, 22:545-551.
83. Grueter B.A., Robison A.J., Neve R.L., Nestler E.J., Malenka R.C. DeltaFosB differentially modulates nucleus accumbens direct and indirect pathway function. Proc Natl Acad Sci USA 2013, 110:1923-1928.
84. Gubellini P., Picconi B., Bari M., Battista N., Calabresi P., Centonze D., Bernardi G., Finazzi-Agro A., Maccarone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci 2002, 22:6900-6907.
85. Haber S.N., Gdowski M.J. The basal ganglia. The human nervous system 2004, 677-719. Academic Press, Amsterdam. G. Paxinos, J.R. Mai (Eds.).
86. Haber S.N., McFarland N.R. The concept of the ventral striatum in nonhuman primates. Ann N Y Acad Sci 1999, 877:33-48.
87. Haber S.N., Kunishio K., Mizobuchi M., Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci 1995, 15:4851-4867.
88. Hamilton D.A., Kolb B. Differential effects of nicotine and complex housing on subsequent experience-dependent structural plasticity in the nucleus accumbens. Behav Neurosci 2005, 119:355-365.
89. Harris K.M., Kater S.B. Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu Rev Neurosci 1994, 17:341-371.
90. Heimer L., Zahm D.S., Churchill L., Kalivas P., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 1991, 41:89-125.
91. Henderson J.M., Carpenter K., Cartwright H., Halliday G.M. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 2000, 123(Pt 7):1410-1421.
92. Henderson J.M., Carpenter K., Cartwright H., Halliday G.M. Degeneration of the centre median-parafascicular complex in Parkinson's disease. Ann Neurol 2000, 47:345-352.
93. Hersch S.M., Ciliax B.J., Gutekunst C.A., Rees H.D., Heilman C.J., Yunk K.K., Bolam J.P., Ince E., Yi H., Levey A.I. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 1995, 15:5222-5237.
94. Hornykiewicz O. Chemical neuroanatomy of the basal ganglia-normal and in Parkinson's disease. J Chem Neuroanat 2001, 22:3-12.
95. Hu M., Becker J.B. Effects of sex and estrogen on behavioral sensitization to cocaine in rats. J Neurosci 2003, 23:693-699.
96. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001, 2:695-703.
97. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
98. Ingham C.A., Hood S.H., Arbuthnott G.W. Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 1989, 503:334-338.
99. Ingham C.A., Hood S.H., van Maldegem B., Weenink A., Arbuthnott G.W. Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. Exp Brain Res 1993, 93:17-27.
100. Ingham C.A., Hood S.H., Taggart P., Arbuthnott G.W. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 1998, 18:4732-4743.
101. Iravani M.M., Syed E., Jackson M.J., Johnston L.C., Smith L.A., Jenner P. A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets. Eur J Neurosci 2005, 21:841-854.
102. Jan C., Pessiglione M., Tremblay L., Tande D., Hirsch E.C., Francois C. Quantitative analysis of dopaminergic loss in relation to functional territories in MPTP-treated monkeys. Eur J Neurosci 2003, 18:2082-2086.
103. Jedynak J.P., Uslaner J.M., Esteban J.A., Robinson T.E. Methamphetamine-induced structural plasticity in the dorsal striatum. Eur J Neurosci 2007, 25:847-853.
104. Jourdain P., Fukunaga K., Muller D. Calcium/calmodulin-dependent protein kinase II contributes to activity-dependent filopodia growth and spine formation. J Neurosci 2003, 23:10645-10649.
105. Kalivas P.W. Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity. Dialogues Clin Neurosci 2007, 9:389-397.
106. Kalivas P.W. Neurobiology of cocaine addiction: implications for new pharmacotherapy. Am J Addict 2007, 16:71-78.
107. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
108. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:1403-1413.
109. Kalivas P.W., Volkow N., Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron 2005, 45:647-650.
110. Kaneko T., Fujiyama F. Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci Res 2002, 42:243-250.
111. Kasai H., Fukuda M., Watanabe S., Hayashi-Takagi A., Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci 2010, 33:121-129.
112. Kashani A., Betancur C., Giros B., Hirsch E., El Mestikawy S. Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging 2007, 28:568-578.
113. Kasture S., Vinci S., Ibba F., Puddu A., Marongiu M., Murali B., Pisanu A., Zernig G., Acquas E. Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study. Neurotox Res 2009, 16:343-355.
114. Kauer J.A., Malenka R.C. Synaptic plasticity and addiction. Nat Rev Neurosci 2007, 8:844-858.
115. Kawaguchi Y., Wilson C.J., Emson P.C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 1990, 10:3421-3438.
116. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical, physiological and morphological characterization. Trends Neurosci 1995, 18:527-535.
117. Kelz M.B., Chen J., Carlezon W.A., Whisler K., Gilden L., Bechmann A.M., Stffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 1999, 401:272-276.
118. Kemp J.M., Powell T.P. The site of termination of afferent fibres in the caudate nucleus. Philos Trans R Soc Lond B Biol Sci 1971, 262:413-427.
119. Kemp J.M., Powell T.P. The synaptic organization of the caudate nucleus. Philos Trans R Soc Lond B Biol Sci 1971, 262:403-412.
120. Kemp J.M., Powell T.P. The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. Philos Trans R Soc Lond B Biol Sci 1971, 262:429-439.
121. Kim Y., Teylan M.A., Baron M., Sands A., Nairn A.C., Greengard P. Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbens. Proc Natl Acad Sci USA 2009, 106:2915-2920.
122. Kim J., Park B.H., Lee J.H., Park S.K., Kim J.H. Cell type-specific alterations in the nucleus accumbens by repeated exposures to cocaine. Biol Psychiatry 2011, 69:1026-1034.
123. Kiraly D.D., Ma X.M., Mazzone C.M., Xin X., Mains R.E., Eipper B.A. Behavioral and morphological responses to cocaine require kalirin7. Biol Psychiatry 2010, 68:249-255.
124. Klug J.R., Mathur B.N., Kash T.L., Wang H.D., Matthews R.T., Robison A.J., Deutch A.Y., Lovinger D.M., Colbran R.J., Winder D.G. Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability. Plos One 2012, 7(9):e45323.
125. Kolb B., Gorny G., Li Y., Samaha A.N., Robinson T.E. Amphetamine or cocaine limits the ability of later experience to promote structural plasticity in the neocortex and nucleus accumbens. Proc Natl Acad Sci USA 2003, 100:10523-10528.
126. Koob G.F. Drug abuse and alcoholism. Overview. Adv Pharmacol 1998, 42:969-977.
127. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
128. Kourrich S., Thomas M.J. Similar neurons, opposite adaptations: psychostimulant experience differentially alters firing properties in accumbens core versus shell. J Neurosci 2009, 29:12275-12283.
129. Kreitzer A.C. Physiology and pharmacology of striatal neurons. Annu Rev Neurosci 2009, 32:127-147.
130. Kreitzer A.C., Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 2007, 445:643-647.
131. Kreitzer A.C., Malenka R.C. Striatal plasticity and basal ganglia circuit function. Neuron 2008, 60:543-554.
132. Kuhar M.J., Ritz M.C., Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 1991, 14:299-302.
133. Kulkarni V.A., Firestein B.L. The dendritic tree and brain disorders. Mol Cell Neurosci 2012, 50:10-20.
134. Kusnoor S.V., Parris J., Muly E.C., Morgan J.I., Deutch A.Y. Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons. J Comp Neurol 2010, 518:2525-2537.
135. Landwehrmeyer B., Mengod G., Palacios J.M. Dopamine D3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 1993, 18:187-192.
136. LaPlant Q., Vialou V., Covington H.E., Dumitriu D., Feng J., Warren B.L., Maze I., Dietz D.M., Watts E.L., Iniguez S.D., Koo J.W., Mouzon E., Renthal W., Hollis F., Wang H., Noonan M.A., Ren Y., Eisch A.J., Bolanos C.A., Kabbaj M., Xiao G., Neve R.L., Hurd Y.L., Oosting R.S., Ganb G., Morrison J.H., Nestler E.J. Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nat Neurosci 2010, 13:1137-1143.
137. Lavoie B., Smith Y., Parent A. Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry. J Comp Neurol 1989, 289:36-52.
138. Lawrence R.C., Otero N.K., Kelly S.J. Selective effects of perinatal ethanol exposure in medial prefrontal cortex and nucleus accumbens. Neurotoxicol Teratol 2012, 34:128-135.
139. Lee K.W., Kim Y., Kim A.M., Helmin K., Nairn A.C., Greengard P. Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. Proc Natl Acad Sci USA 2006, 103:3399-3404.
140. Li Y., Kolb B., Robinson T.E. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 2003, 28:1082-1085.
141. Li Y., Acerbo M.J., Robinson T.E. The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci 2004, 20:1647-1654.
142. Li J., Liu N., Lu K., Zhang L., Gu J., Guo F., An S., Zhang L., Zhang L. Cocaine-induced dendritic remodeling occurs in both D1 and D2 dopamine receptor-expressing neurons in the nucleus accumbens. Neurosci Lett 2012, 517:118-122.
143. 2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J Neurosci 2010, 30:939-949.
144. Lynd-Balta E., Haber S.N. The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum. Neuroscience 1994, 59:625-640.
145. Lynd-Balta E., Haber S.N. The organization of midbrain projections to the ventral striatum in the primate. Neuroscience 1994, 59:609-623.
146. Ma X.M., Huang J.P., Xin X., Yan Y., Mains R.E., Eipper B.A. A role for kalirin in the response of rat medium spiny neurons to cocaine. Mol Pharmacol 2012, 82:738-745.
147. Mains R.E., Kiraly D.D., Eipper-Mains J.E., Ma X.M., Eipper B.A. Kalrn promoter usage and isoform expression respond to chronic cocaine exposure. BMC Neurosci 2011, 12:20.
148. Malinow R., Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002, 25:103-126.
149. Mao Z., Wiedmann M. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J Biol Chem 1999, 274:31102-31107.
150. Marie N., Canestrelli C., Noble F. Transfer of neuroplasticity from nucleus accumbens core to shell is required for cocaine reward. PLoS One 2012, 7:e30241.
151. Martin K.C., Zukin R.S. RNA trafficking and local protein synthesis in dendrites: an overview. J Neurosci 2006, 26:7131-7134.
152. Martin B.J., Naughton B.J., Thirtamara-Rajamani K., Yoon D.J., Han D.D., Devries A.C., Gu H.H. Dopamine transporter inhibition is necessary for cocaine-induced increases in dendritic spine density in the nucleus accumbens. Synapse 2011, 65:490-496.
153. Massie A., Schallier A., Vermoesen K., Arckens L., Michotte Y. Biphasic and bilateral changes in striatal VGLUT1 and 2 protein expression in hemi-Parkinson rats. Neurochem Int 2010, 57:111-118.
154. Matsuda W., Furuta T., Nakamura K.C., Hioki H., Fujiyama F., Arai R., Kaneko T. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 2009, 29:444-453.
155. Maze I., Covington H.E., Dietz D.M., LaPlant Q., Renthal W., Russo S.J., Mechanic M., Mouzon E., Neve R.L., Haggarty S.J., Ren Y., Sampath S.C., Hurd Y.L., Greengard P., Taraknovsky A., Scahefer A., Nestler E.J. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010, 327:213-216.
156. McGeorge A.J., Faull R.L. The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain. Brain Res 1987, 423:318-324.
157. McNeill T.H., Brown S.A., Rafols J.A., Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988, 455:148-152.
158. McNeill T.H., Brown S.A., Hogg E., Cheng H.W., Meshul C.K. Synapse replacement in the striatum of the adult rat following unilateral cortex ablation. J Comp Neurol 2003, 467:32-43.
159. Meredith G.E., Agolia R., Arts M.P., Groenewegen H.J., Zahm D.S. Morphological differences between projection neurons of the core and shell in the nucleus accumbens of the rat. Neuroscience 1992, 50:149-162.
160. Meshul C.K., Emre N., Nakamura C.M., Allen C., Donohue M.K., Buckman J.F. Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion. Neuroscience 1999, 88:1-16.
161. Meshul C.K., Cogen J.P., Cheng H.W., Moore C., Krentz L., McNeill T.H. Alterations in rat striatal glutamate synapses following a lesion of the cortico- and/or nigrostriatal pathway. Exp Neurol 2000, 165:191-206.
162. Moss J., Bolam J.P. A dopaminergic axon lattice in the striatum and its relationship with cortical and thalamic terminals. J Neurosci 2008, 28:11221-11230.
163. Muhammad A., Kolb B. Maternal separation altered behavior and neuronal spine density without influencing amphetamine sensitization. Behav Brain Res 2011, 223:7-16.
164. Muhammad A., Kolb B. Mild prenatal stress-modulated behavior and neuronal spine density without affecting amphetamine sensitization. Dev Neurosci 2011, 33:85-98.
165. Muhammad A., Mychasiuk R., Nakahashi A., Hossain S.R., Gibb R., Kolb B. Prenatal nicotine exposure alters neuroanatomical organization of the developing brain. Synapse 2013, 66:950-954.
166. Mychasiuk R., Muhammad A., Gibb R., Kolb B. Long-term alterations to dendritic morphology and spine density associated with prenatal exposure to nicotine. Brain Res 2013, 1499:53-60.
167. Nakatani-Pawlak A., Yamaguchi K., Tatsumi Y., Mizoguchi H., Yoneda Y. Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood. Biol Pharm Bull 2009, 32:1576-1583.
168. Neely M.D., Schmidt D.E., Deutch A.Y. Cortical regulation of dopamine depletion-induced dendritic spine loss in striatal medium spiny neurons. Neuroscience 2007, 149:457-464.
169. Nestler E.J. Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos Trans R Soc Lond B Biol Sci 2008, 363:3245-3255.
170. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13:1161-1169.
171. Nicola S.M., Surmeier J., Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 2000, 23:185-215.
172. Nishijima H., Arai A., Kimura T., Mori F., Yamada J., Migita K., Wakabayashi K., Baba M., Ueno S., Tomiyama M. Drebrin immunoreactivity in the striatum of a rat model of levodopa-induced dyskinesia. Neuropathology 2013, 33:391-396.
173. Norrholm S.D., Bibb J.A., Nestler E.J., Ouimet C.C., Taylor J.R., Greengard P. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 2003, 116:19-22.
174. Oorschot D.E. Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods. J Comp Neurol 1996, 366:580-599.
175. Pal A., Das S. Chronic morphine exposure and its abstinence alters dendritic spine morphology and upregulates Shank1. Neurochem Int 2013, 62:956-964.
176. Parent A. Comparative neurology of the basal ganglia 1986, John Wiley & Sons, New York, p. 335.
177. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 1995, 20:91-127.
178. Pennartz C.M., Groenewegen H.J., Lopes da Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 1994, 42:719-761.
179. Perrotti L.I., Weaver R.R., Robison B., Renthal W., Maze I., Yazdani S., Elmore R.G., Knapp D.J., Selley D.E., Martin B.R., Sim-Selley L., Bachtell R.K., Self D.W., Nestler E.J. Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 2008, 62:358-369.
180. Picconi B., Piccoli G., Calabresi P. Synaptic dysfunction in Parkinson's disease. Adv Exp Med Biol 2012, 970:553-572.
181. Pissadaki E.K., Bolam J.P. The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease. Front Comput Neurosci 2013, 7:13.
182. Prensa L., Parent A. The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J Neurosci 2001, 21:7247-7260.
183. Pulipparacharuvil S., Renthal W., Hale C.F., Taniguchi M., Xiao G., Kumar A., Russo S.J., Sikder D., Dewey C.M., Davis M.M., Greengard P., Nairn A.C., Nestler E.J., Cowan C.W. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 2008, 59:621-633.
184. Raju D.V., Shah D.J., Wright T.M., Hall R.A., Smith Y. Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J Comp Neurol 2006, 499:231-243.
185. Raju D.V., Ahern T.H., Shah D.J., Wright T.M., Standaert D.G., Hall R., Smith Y. Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. Eur J Neurosci 2008, 27:1647-1658.
186. Ren Z., Sun W.L., Jiao H., Zhang D., Kong H., Wang X., Xu M. Dopamine D1 and N-methyl-d-aspartate receptors and extracellular signal-regulated kinase mediate neuronal morphological changes induced by repeated cocaine administration. Neuroscience 2010, 168:48-60.
187. Reynolds J.N., Wickens J.R. Dopamine-dependent plasticity of corticostriatal synapses. Neural Netw 2002, 15:507-521.
188. Rice M.E., Cragg S.J. Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res Rev 2008, 58:303-313.
189. Rice M.E., Patel J.C., Cragg S.J. Dopamine release in the basal ganglia. Neuroscience 2011, 198:112-137.
190. Rice J.P., Suggs L.E., Lusk A.V., Parker M.O., Candelaria-Cook F.T., Akers K.G., Sabage D.D., Hamilton D.A. Effects of exposure to moderate levels of ethanol during prenatal brain development on dendritic length, branching, and spine density in the nucleus accumbens and dorsal striatum of adult rats. Alcohol 2012, 46:577-584.
191. Rivera A., Cuellar B., Giron F.J., Grandy D.K., de la Calle A., Moratalla R. Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J Neurochem 2002, 80:219-229.
192. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997, 17:8491-8497.
193. Robinson T.E., Kolb B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 1999, 11:1598-1604.
194. Robinson T.E., Kolb B. Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats. Synapse 1999, 33:160-162.
195. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47(Suppl. 1):33-46.
196. Robinson T.E., Gorny G., Mitton E., Kolb B. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001, 39:257-266.
197. Robinson T.E., Gorny G., Savage V.R., Kolb B. Widespread, but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 2002, 46:271-279.
198. Robison A.J., Vialou V., Mazei-Robison M., Feng J., Kourrich S., Collins M., We S., Koon G., Turecki G., Neve R., Thomas M., Nestler E.J. Behavioral and structural responses to chronic cocaine require a feedforward loop involving DeltaFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell. J Neurosci 2013, 33:4295-42307.
199. Russchen F.T., Bakst I., Amaral D.G., Price J.L. The amygdalostriatal projections in the monkey. An anterograde tracing study. Brain Res 1985, 329:241-257.
200. Russo S.J., Wilkinson M.B., Mazei-Robison M.S., Dietz D.M., Maze I., Krishnan V., Renthal W., Graham A., Birnbaum S.G., Green T.A., Robison B., Lesselyong A., Perrotti L.I., Bolaños C.A., Kumar A., Clark M.S., Neumaier J.F., Neve R.L., Bhakar A.L., Barker P.A., Nestler E.J. Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci 2009, 29:3529-3537.
201. Russo S.J., Dietz D.M., Dumitriu D., Morrison J.H., Malenka R.C., Nestler E.J. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci 2010, 33:267-276.
202. Safiulina D., Veksler V., Zharkovsky A., Kaasik A. Loss of mitochondrial membrane potential is associated with increase in mitochondrial volume: physiological role in neurones. J Cell Physiol 2006, 206:347-353.
203. Salas-Ramirez K.Y., Frankfurt M., Alexander A., Luine V.N., Friedman E. Prenatal cocaine exposure increases anxiety, impairs cognitive function and increases dendritic spine density in adult rats: influence of sex. Neuroscience 2010, 169:1287-1295.
204. Scholz B., Svensson M., Alm H., Skold K., Falth M., Kultima K., Guigoni C., Doudnikoff E., Li Q., Crossman A.R., Bezard E., Andrén P.E. Striatal proteomic analysis suggests that first l-dopa dose equates to chronic exposure. PLoS One 2008, 3:e1589.
205. 2+ channel reduces development of abnormal involuntary movement in the rat model of l-3,4-dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry 2009, 65:518-526.
206. Shen W., Flajolet M., Greengard P., Surmeier D.J. Dichotomous dopaminergic control of striatal synaptic plasticity. Science 2008, 321:848-851.
207. Shen H.W., Toda S., Moussawi K., Bouknight A., Zahm D.S., Kalivas P.W. Altered dendritic spine plasticity in cocaine-withdrawn rats. J Neurosci 2009, 29:2876-2884.
208. Shen H., Moussawi K., Zhou W., Toda S., Kalivas P.W. Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors. Proc Natl Acad Sci USA 2011, 108:19407-19412.
209. Singer B.F., Tanabe L.M., Gorny G., Jake-Matthews C., Li Y., Kolb B., Vezina P. Amphetamine-induced changes in dendritic morphology in rat forebrain correspond to associative drug conditioning rather than nonassociative drug sensitization. Biol Psychiatry 2009, 65:835-840.
210. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 1990, 13:259-265.
211. Smith Y., Parent A. Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimiri sciureus). Neuroscience 1986, 18:347-371.
212. Smith Y., Bennett B.D., Bolam J.P., Parent A., Sadikot A.F. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J Comp Neurol 1994, 344:1-19.
213. Smith Y., Bevan M.D., Shink E., Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998, 86:353-387.
214. Smith Y., Raju D.V., Pare J.F., Sidibe M. The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci 2004, 27:520-527.
215. Smith Y., Raju D., Nanda B., Pare J.F., Galvan A., Wichmann T. The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states. Brain Res Bull 2009, 78:60-68.
216. Smith Y., Villalba R.M., Raju D.V. Striatal spine plasticity in Parkinson's disease: pathological or not?. Parkinsonism Relat Disord 2009, 15(Suppl. 3):S156-S161.
217. Smith Y., Wichmann T., Factor S.A., DeLong M.R. Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsychopharmacology 2012, 37:213-246.
218. Smith RJ, Lobo MK, Spencer S, Kalivas PW (2013) Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). Curr Opin Neurobiol, in press,. http://dx.doi.org/10.1016/j.conb.2013.01.026.
219. Soderstrom K.E., O'Malley J.A., Levine N.D., Sortwell C.E., Collier T.J., Steece-Collier K. Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats. Eur J Neurosci 2010, 31:478-490.
220. Solis O., Limon D.I., Flores-Hernandez J., Flores G. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 2007, 61:450-458.
221. Solis O., Vazquez-Roque R.A., Camacho-Abrego I., Gamboa C., De La Cruz F., Zamudio S., Flores G. Decreased dendritic spine density of neurons of the prefrontal cortex and nucleus accumbens and enhanced amphetamine sensitivity in postpubertal rats after a neonatal amygdala lesion. Synapse 2009, 63:1143-1153.
222. Spiga S., Puddu M.C., Pisano M., Diana M. Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur J Neurosci 2005, 22:2332-2340.
223. Staffend N.A., Loftus C.M., Meisel R.L. Estradiol reduces dendritic spine density in the ventral striatum of female Syrian hamsters. Brain Struct Funct 2011, 215:187-194.
224. Stephens B., Mueller A.J., Shering A.F., Hood S.H., Taggart P., Arbuthnott G.W., Bell J.E., Kilford L., Kingsbury A.E., Daniel S.E., Ingham C.A. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 2005, 132:741-754.
225. Suarez LM, Solis O, Carames JM, Taravini IR, Solis JM, Murere MG, Moratalla R (2013) L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice. Biol Psychiatry, in press.
226. Surmeier D.J., Ding J., Day M., Wang Z., Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007, 30:228-235.
227. Surmeier D.J., Shen W., Day M., Gertler T., Chan S., Tian X., Plotkin J.L. The role of dopamine in modulating the structure and function of striatal circuits. Prog Brain Res 2010, 183:149-167.
228. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 2000, 407:189-194.
229. Takamori S., Rhee J.S., Rosenmund C., Jahn R. Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci 2001, 21:RC182.
230. Tepper J.M., Bolam J.P. Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 2004, 14:685-692.
231. Tian X., Kai L., Hockberger P.E., Wokosin D.L., Surmeier D.J. MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci 2010, 44:94-108.
232. Toda S., Shen H., Kalivas P.W. Inhibition of actin polymerization prevents cocaine-induced changes in spine morphology in the nucleus accumbens. Neurotox Res 2010, 18:410-415.
233. Van Dongen Y.C., Deniau J.M., Pennartz C.M., Galis-de-Graaf Y., Voorn P., Thierry A.M., Groenewegen H.J. Anatomical evidence for direct connections between the shell and core subregions of the rat nucleus accumbens. Neuroscience 2005, 136:1049-1071.
234. van Haaren F., Meyer M.E. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol Biochem Behav 1991, 39:923-927.
235. van Spronsen M., Hoogenraad C.C. Synapse pathology in psychiatric and neurologic disease. Curr Neurol Neurosci Rep 2010, 10:207-214.
236. Verstreken P., Ly C.V., Venken K.J., Koh T.W., Zhou Y., Bellen H.J. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005, 47:365-378.
237. Villalba R.M., Smith Y. Striatal spine plasticity in Parkinson's disease. Front Neuroanat 2010, 4:133.
238. Villalba R.M., Smith Y. Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J Comp Neurol 2011, 519:989-1005.
239. Villalba R.M., Smith Y. Neuroglial plasticity at striatal glutamatergic synapses in Parkinson's disease. Front Syst Neurosci 2011, 5:68.
240. Villalba R.M., Lee H., Smith Y. Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys. Exp Neurol 2009, 215:220-227.
241. Villalba RM, Wichmann T, Smith Y (2013) Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease. Brain Struct Func, in press,. http://dx.doi.org/10.1007/s00429-013-0507-9.
242. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 2011, 52:321-336.
243. Volkow N.D., Wang G.J., Fowler J.S., Tomasi D., Telang F. Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 2011, 108:15037-15042.
244. Walker R.H., Moore C., Davies G., Dirling L.B., Koch R.J., Meshul C.K. Effects of subthalamic nucleus lesions and stimulation upon corticostriatal afferents in the 6-hydroxydopamine-lesioned rat. PLoS One 2012, 7:e32919.
245. Wang H., Pickel V.M. Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus. J Comp Neurol 2002, 442:392-404.
246. Wang Z., Kai L., Day M., Ronesi J., Yin H.H., Ding J., Tkatch T., Lovinger D.M., Surmeier D.J. Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron 2006, 50:443-452.
247. Waselus M, Flagel SB, Jedynak JP, Akil H, Robinson TE, Watson JR SJ (2013) Long-term effects of cocaine experience on neuroplasticity in the nucleus acumbens core of addiction-prone rats. Neuroscience, in press.
248. White F.J., Kalivas P.W. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend 1998, 51:141-153.
249. Wichmann T., DeLong M.R. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder. Ann N Y Acad Sci 2003, 991:199-213.
250. Wichmann T., Delong M.R. Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disorders. Handb Clin Neurol 2007, 83:1-18.
251. Wickens J.R., Arbuthnott G.W., Shindou T. Simulation of GABA function in the basal ganglia: computational models of GABAergic mechanisms in basal ganglia function. Prog Brain Res 2007, 160:313-329.
252. Winstanley C.A., Bachtell R.K., Theobald D.E., Laali S., Green T.A., Kumar A., Chakravarty S., Self D.W., Nestlet E.J. Increased impulsivity during withdrawal from cocaine self-administration: role for DeltaFosB in the orbitofrontal cortex. Cereb Cortex 2009, 19:435-444.
253. Winstanley C.A., Green T.A., Theobald D.E., Renthal W., LaPlant Q., DiLeone R.J., Chakravarty S., Nestler E.J. DeltaFosB induction in orbitofrontal cortex potentiates locomotor sensitization despite attenuating the cognitive dysfunction caused by cocaine. Pharmacol Biochem Behav 2009, 93:278-284.
254. Wissman A.M., McCollum A.F., Huang G.Z., Nikrodhanond A.A., Woolley C.S. Sex differences and effects of cocaine on excitatory synapses in the nucleus accumbens. Neuropharmacology 2011, 61:217-227.
255. Wissman A.M., May R.M., Woolley C.S. Ultrastructural analysis of sex differences in nucleus accumbens synaptic connectivity. Brain Struct Funct 2012, 217:181-190.
256. Wolf M.E. The Bermuda Triangle of cocaine-induced neuroadaptations. Trends Neurosci 2010, 33:391-398.
257. Wu Y., Richard S., Parent A. The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res 2000, 38:49-62.
258. 2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade. Neuron 1997, 19:1115-1126.
259. 2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J Neurophysiol 1997, 77:1003-1015.
260. Yung K.K., Bolam J.P., Smith A.D., Hersch S.M., Ciliax B.J., Levey A.I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 1995, 65:709-730.
261. Yuste R., Bonhoeffer T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 2001, 24:1071-1089.
262. Yuste R., Bonhoeffer T. Genesis of dendritic spines: insights from ultrastructural and imaging studies. Nat Rev Neurosci 2004, 5:24-34.
263. Yuste R., Denk W. Dendritic spines as basic functional units of neuronal integration. Nature 1995, 375:682-684.
264. Yuste R., Majewska A. On the function of dendritic spines. Neuroscientist 2001, 7:387-395.
265. Zahm D.S., Brog J.S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 1992, 50:751-767.
266. Zaja-Milatovic S., Milatovic D., Schantz A.M., Zhang J., Montine K.S., Samii A., Deutch A.Y., Montine T.J. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005, 64:545-547.
267. Zhang L., Li J., Liu N., Wang B., Gu J., Zhang M., Zhou Z., Jiang Y., Zhang L., Zhang L. Signaling via dopamine D1 and D3 receptors oppositely regulates cocaine-induced structural remodeling of dendrites and spines. Neurosignals 2012, 20:15-34.
268. Zhang Y., Meredith G.E., Mendoza-Elias N., Rademacher D.J., Tseng K.Y., Steece-Collier K. Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: Involvement of corticostriatal but not thalamostriatal synapses. J Neurosci 2013, 33:11655-11667.
269. Zhou F.C., Anthony B., Dunn K.W., Lindquist W.B., Xu Z.C., Deng P. Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens. Brain Res 2007, 1134:148-161.